Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">PSI-938: Phase I started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

Pharmasset began a single ascending-dose Phase I trial to evaluate PSI-938 in healthy volunteers. ......

Hepatic

Infectious

PSI-938: Phase I started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

BioCentury-BayHelix East-West Summit 2027

East-West Biopharma Summit

Podcast: The BioCentury Show

Podcast: BioCentury This Week

Webinars

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Subscription

Sponsorship & Branding Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Request a Trial

Contact

Home